Neuroimaging Findings in the Evaluation of Dementia: A Review
Learning Objective: Describe the salient neuroimaging findings that distinguish the different types of dementia discussed in the article.
Keywords: AD = Alzheimer disease; ADC = apparent diffusion coefficient; APD = atypical parkinsonian disorder; CAA = cerebral amyloid angiopathy; CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarctions and leukoencephalopathy; CJD = Creutzfeldt-Jakob disease; CSF = cerebrospinal fluid; CT = computed tomography; DLB = dementia with Lewy bodies; DTI = diffusion tensor imaging; DWI = diffusion-weighted imaging; DaTscan = iodine 123 3-fluoropropyl-2-beta-carbomethoxy-3-beta(4-iodophenyl) nortropane; FDG = fluorodeoxyglucose; FLAIR = fluid attenuated inversion recovery; FP-CIT = fluoropropyl-2-beta-carbomethoxy-3-beta(4-iodophenyl) nortropane; FTD = frontotemporal dementia; GRE = gradient recalled echo; L-Dopa = levodopa; MCI = mild cognitive impairment; MRPI = magnetic resonance parkinsonism index; MSA = multisystem atrophy; MSA-c = multisystem atrophy predominant cerebellar; MSA-p = multisystem atrophy predominant parkinsonism; NPH = normal pressure hydrocephalus; PD = Parkinson disease; PET = positron emission tomography; PPA = primary progressive aphasia; PSP = progressive supranuclear palsy; SN = substantia nigra; SPECT; SPECT = single-photon emission computed tomography; SS = superficial siderosis; SWI = susceptibility-weighted imaging; cSS = cortical superficial siderosis; sCJD = sporadic Creutzfeldt-Jakob disease; vCJD = variant Creutzfeldt-Jakob disease
Document Type: Research Article
Publication date: 01 November 2017
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content